OMED Pharmaceuticals elevates skincare in Sri Lanka with mesoestetic®’s Advanced Solutions
OMED Pharmaceuticals (Pvt) Ltd, a leading distributor and exclusive agent for high-quality international skincare and aesthetic brands in Sri Lanka, together with mesoestetic®, a global leader in the medical cosmetics and aesthetic medicine sector, conducted an exclusive client event on 23 November 2024 at Elevate by Jetwing to engage with skincare professionals in Sri Lanka about its cutting-edge products and educational resources.
The event, which was exclusively attended by dermatologists, highlighted mesoestetic®’s commitment to providing high-quality, dermatologically tested skincare solutions for the country through its exclusive local partner, OMED Pharmaceuticals. This collaboration emphasizes the brand’s dedication to advanced Research, Development, and Innovation (R&D&I) in addressing diverse skincare needs, ensuring scientifically backed and effective products for dermatological and aesthetic care. With a 44% R&D&I budget, mesoestetic®’s progress is linked to ongoing research and collaboration with hospitals, universities and experienced specialists from the sector as the company works closely with these to research and develop new treatments.
Having already established itself in 109 countries across the globe through 94 official distributors, mesoestetic® has now expanded its footprint in Sri Lanka by partnering with OMED Pharmaceuticals as its Exclusive Agent. Together, mesoestetic® aims to introduce products specifically tailored to address Sri Lanka’s common skincare concerns, including pigmentation, sun damage, and acne. By leveraging OMED Pharmaceuticals’ robust distribution network and expertise, mesoestetic® is strengthening its e-commerce presence and delivery services to ensure seamless access across the country. This collaboration underscores a shared commitment to quality, innovation, and sustainability, positioning OMED Pharmaceuticals as a key driver of mesoestetic®’s success in Sri Lanka.
More Read
Founded in 2019 by Shervin Mario Lindsay, OMED Pharmaceuticals is a leader in dermatological and aesthetic skincare solutions in Sri Lanka. The company’s mission is to provide advanced, science-backed skincare solutions tailored to the unique needs of Sri Lanka’s modern consumers. As the exclusive local partner, OMED Pharmaceuticals plays a critical role in making mesoestetic®’s innovative solutions accessible to professionals and consumers across Sri Lanka, reinforcing their shared commitment to excellence in skincare.
Sharing his views about the partnership, Shervin Mario Lindsay – Director of OMED Pharmaceuticals stated, “OMED Pharmaceuticals plays a pivotal role in bringing mesoestetic®’s advanced skincare solutions to the Sri Lankan market, ensuring their availability through collaborations with dermatologists, aesthetic clinics, and pharmacies nationwide. The partnership is focused on empowering local skincare professionals with educational workshops and training programs while raising consumer awareness about the benefits of science-backed skincare and clinically-validated products.”
OMED Pharmaceuticals offers a wide range of professional-grade products for various dermatological concerns such as pigmentation, acne, anti-aging, and post-aesthetic care. In addition to distributing trusted brands, the company is committed to educating dermatologists, aesthetic professionals, and consumers through workshops and training programs. With a focus on innovation and sustainability, the company ensures that all its products meet global safety and quality standards. OMED Pharmaceuticals works closely with leading dermatologists and clinics across Sri Lanka, providing personalized solutions and excellent customer support. Under the leadership of Shervin Mario Lindsay, the company aims to set new benchmarks in skincare and aesthetic care, making high-quality treatments accessible to all.
Caption:
OMED 1: OMED Pharmaceuticals Director Shervin Mario Lindsay
OMED 2: mesoestetic Pharma Group Export Area Manager – Central Asia and Middle East Núria Ribera Garcia
